Browsing by Author "Akinpelu, Sharon O."

Now showing 1 - 3 of 3

A possible role of urinary genotoxic Escherichia coli in prostate cancer in Nigerian patients
(BMC Research Notes, 2025) Akinpelu, Sharon O.; Olasehinde, Grace I.; Akinnola, Olayemi O.
Objective Infection and inflammation are potential initiating factors for the development and progression of prostate cancer. This study investigated the presence of bacterial genotoxins; colibactin (clb) and cytolethal distending toxin (cdt) in Escherichia coli isolated from urine samples of individuals diagnosed with prostate cancer as well as those with benign prostatic hyperplasia. E. coli was isolated from urine samples from prostate cancer patients (cases, n = 30) and men with benign prostate hyperplasia (controls, n = 40). The presence of colibactin (clb) and cytolethal distending toxin (cdt) genes was evaluated in E. coli isolates using polymerase chain reaction. Results The frequency of E. coli was 36.0% of prostate cancer patients and 30.0% of controls, respectively (p = 0.557). Furthermore, there was a higher occurrence of the clb gene in cases compared to controls (36.4% vs. 8.3%). Cytolethal distending toxin (cdt) gene was absent in all isolates examined. The analysis revealed no significant relationship between the selected genotoxins and prostate cancer (p = 0.104). The Gleason grade of the cancer was not a major determinant in the occurrence of clb within the cancer cases. The present study is the first report investigating bacterial genotoxins in urine samples of Nigerian prostate cancer patients. Our findings showed no association between bacterial genotoxins and prostate cancer. Additional investigations are warranted to further investigate the role of bacterial genotoxins in prostate cancer development.
Prevalence and antibiotic susceptibility patterns of uropathogens in men with prostate cancer and benign prostate hyperplasia from Southwestern Nigeria
(BMC Microbiology, 2024) Akinpelu, Sharon O.; Olasehinde, Grace I.; kuerowo, Stephen O.; Akinnola, Olayemi O.
Background Epidemiological investigations have revealed an important association between infection, inflammation and prostate cancer. Certain bacterial species, such as Klebsiella spp, Escherichia coli, Pseudomonas spp, Proteus mirabilis, Chlamydia trachomatis have been linked to prostate cancer. This study aimed to examine the microbiota; specifically bacterial species that have been linked to prostate infections in the urine of individuals diagnosed with prostate cancer. Results Sixty-six prostate cancer patients and forty controls provided midstream urine samples. The urine samples were grown on suitable medium, and bacterial isolates were detected by standard microbiological methods. Additionally, the antibiotic sensitivity pattern of the bacterial isolates was analysed. A total of number of 72 bacterial isolates were obtained from the urine of study participants. The results showed the presence of Escherichia coli (50.0%), Pseudomonas aeruginosa (18.1%), Klebsiella spp (15.3%), Staphylococcus aureus (8.3%), Enterobacter spp (4.2%), and Proteus mirabilis (2.8%) in the urine. The most common bacterial species isolated from prostate cancer patients was Escherichia coli, which was susceptible to levofloxacin (100%), tobramycin (91.7%), and amikacin (62.5%). Conclusions This study’s findings established the presence of bacteria previously linked to prostatitis. This report indicates a high prevalence of pro-inflammatory bacteria and uropathogens in the urinary tract of men diagnosed with prostate cancer
Prevalence and associated risk factors of Staphylococcus aureus nasal colonization among a cohort of immunocompromised individuals in Lagos, Nigeria
(BMC Infectious Diseases, 2025) Ogunleye, Bimpe O.; Oshamika, Oyewumi O.; Akinpelu, Sharon O.; Ajayi, Ayodeji S.; Akinduti, Paul A.; Oyedeji, Kolawole S.; Odeniy, Olalekan M.; Akinnola, Olayemi O.
Background Immunocompromised individuals are highly vulnerable to Staphylococcus aureus (S. aureus) infections, leading to increased morbidity and mortality. This study aimed to assess the prevalence, virulence, and risk factors associated with S. aureus nasal carriage among immunocompromised individuals in Lagos, Nigeria. Methods A total of 350 participants were enrolled, including 150 HIV/AIDS cases, 50 HIV/TB co-infections, 100 diabetes cases, and 50 controls. Nasal swabs were collected and cultured on Mannitol salt agar for the isolation of Staphylococcus aureus. Presumptive isolates were confirmed using Gram staining, catalase, and coagulase tests. Antimicrobial susceptibility was determined using the Kirby-Bauer disk diffusion method in accordance with CLSI guidelines. Molecular detection of resistance and virulence genes was performed using PCR targeting the mecA gene (methicillin resistance) and pvl (Panton-Valentine leukocidin). A structured questionnaire capturing clinical history and hygiene practices was used to evaluate risk factors for S. aureus carriage. Results The overall prevalence of S. aureus was 14.6% (51/350), S. aureus was isolated in 28% (14/50) of controls, 16.7% (25/150) of HIV/AIDS patients, 14% (7/50) of HIV/TB cases and 5% (5/100) of diabetes cases. Susceptibility to erythromycin was 80.4%, gentamycin, ciprofloxacin and Sulfamethoxazole-Trimethoprim (64.7%) among all S. aureus isolated. Methicillin-resistant S. aureus (MRSA) was detected in 78.4% (40/51) of isolates, predominantly among HIV/AIDS patients (52.5%). pvl genes were identified in 11.8% (6/51) of isolates. S. aureus carriage was significantly associated with recent antibiotic use (p = 0.003) and contact with animals (p = 0.018). Conclusion This study demonstrates a high prevalence of S. aureus among controls compared to immunocompromised individuals. These results highlight the need for further studies to elucidate the relationship between host factors and S. aureus colonization. This could inform targeted strategies for infection prevention and control.